Therapeutic area intelligence for Traumatic Brain Injury with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

No related entities indexed yet.

Recent signals(3)

ClinicalAugust 14, 2026

Study on Magnesium Sulfate's Anti-inflammatory Effects in Moderate TBI Patients

A clinical trial is underway to assess the efficacy of Magnesium Sulfate in reducing inflammation in moderate TBI patients at Assiut University.

ClinicalJuly 10, 2026

Study on Traumatic Brain Injury Pathogenesis and Outcomes by NINDS

A study is being conducted to evaluate MRI results and the natural evolution of traumatic brain injury over three months.

ClinicalJune 30, 2026

Study on TBI Assessment Using TMS and Delphi-MD Device Initiated

A clinical trial assessing traumatic brain injury using transcranial magnetic stimulation has been initiated.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.